Table 3.

Prostate-Cancer Specific Survival According to Alternate Definitions for ADT

Survival (days)	Adjuvant ADT Use		Subdistribution HR for Death in Adjuvant ADT Group	95% CI
	No. of Patients With No Adjuvant ADT	No. of Patients With Adjuvant ADT
90	543	188	1.22	0.69 to 2.16
120	522	209	0.97	0.56 to 1.68
150	511	220	1.15	0.67 to 1.97
180	501	230	1.53	0.90 to 2.61
365	473	258	1.96	1.16 to 3.29

Abbreviations: ADT, androgen deprivation therapy; HR, hazard ratio.